Array Insights, formerly known as Secure AI Labs, is a company based in Cambridge, Massachusetts, founded in 2017. It specializes in providing a secure analytics platform that enables businesses to share sensitive and regulated data without compromising security or ownership. Its technology employs encryption to protect data throughout the analysis process, allowing users to access siloed information while utilizing proprietary algorithms. The platform enforces data-use policies, giving data owners control over who can use their information and how it is utilized, even after sharing. Array Insights focuses on the healthcare sector, offering a clinical data registry that allows hospitals to securely manage patient data and conduct research efficiently, all while ensuring compliance with regulatory standards. The company combines bioinformatics and machine learning to create accessible AI models from a diverse library, facilitating the safe use of personal and proprietary information in research and analysis.
Outcomes4me Inc. is a healthcare technology company based in Cambridge, Massachusetts, founded in 2017. It has developed a free mobile application and platform designed to empower patients navigating cancer treatment and care. The platform connects patients with healthcare providers and offers personalized, expert-validated information, enabling users and their families to make informed decisions about their treatment options. Outcomes4me also provides clinical trial services and generates real-world evidence to enhance clinical decision-making and improve patient outcomes. The company's mission is to ensure that patients are actively engaged in their healthcare journey, facilitating access to tailored treatment information and resources.
Carta Healthcare, Inc. is a technology company that has developed a software-as-a-service platform to enhance the patient journey within hospitals by utilizing data from existing IT systems. Founded in 2016 and headquartered in San Mateo, California, Carta's platform aims to personalize care by identifying past patients with similar profiles and analyzing their experiences. By employing machine learning, the platform predicts potential bottlenecks, alerts facilities about recovery bed shortages, and forecasts the needs and expectations of current patients. Additionally, Carta combines artificial intelligence with skilled human expertise to improve the efficiency and quality of healthcare data management, ultimately enabling health systems to achieve more effective data abstraction.
Aavia is a company founded in 2017 and based in Brooklyn, New York, dedicated to improving female health and wellness through innovative technology. It has developed a health tracker platform that assists women in managing their hormonal changes and taking birth control pills on time. The platform enables users to monitor their hormone cycles and understand the effects of hormonal fluctuations on various aspects of their health, including mood, skin, and sleep. By providing these insights, Aavia aims to empower women to prevent healthcare crises related to hormonal imbalances. The company's name, inspired by the image of a bird, symbolizes strength and freedom in navigating personal health.
Array Insights, formerly known as Secure AI Labs, is a company based in Cambridge, Massachusetts, founded in 2017. It specializes in providing a secure analytics platform that enables businesses to share sensitive and regulated data without compromising security or ownership. Its technology employs encryption to protect data throughout the analysis process, allowing users to access siloed information while utilizing proprietary algorithms. The platform enforces data-use policies, giving data owners control over who can use their information and how it is utilized, even after sharing. Array Insights focuses on the healthcare sector, offering a clinical data registry that allows hospitals to securely manage patient data and conduct research efficiently, all while ensuring compliance with regulatory standards. The company combines bioinformatics and machine learning to create accessible AI models from a diverse library, facilitating the safe use of personal and proprietary information in research and analysis.
Outcomes4me Inc. is a healthcare technology company based in Cambridge, Massachusetts, founded in 2017. It has developed a free mobile application and platform designed to empower patients navigating cancer treatment and care. The platform connects patients with healthcare providers and offers personalized, expert-validated information, enabling users and their families to make informed decisions about their treatment options. Outcomes4me also provides clinical trial services and generates real-world evidence to enhance clinical decision-making and improve patient outcomes. The company's mission is to ensure that patients are actively engaged in their healthcare journey, facilitating access to tailored treatment information and resources.
Lark Technologies, Inc. is a developer of a chronic disease prevention and management platform headquartered in Mountain View, California. Founded in 2010, the company provides the Lark application, which utilizes artificial intelligence alongside human coaching to deliver personalized, real-time support for individuals managing chronic conditions such as diabetes, prediabetes, and hypertension. The platform also integrates data on user activity, sleep, and nutrition to enhance health outcomes. Lark's programs, including its CDC-recognized Diabetes Prevention Program and Hypertension Program, have garnered around 1.5 million users and are backed by clinical evidence published in peer-reviewed journals. The company serves employers and health plans, aiming to deliver compassionate care at scale.
OneStudyTeam, a subsidiary of Reify Health, offers a cloud-based software platform designed to enhance the efficiency of clinical trial processes. The platform aims to simplify workflows for clinical trial teams, enabling faster and more predictable patient enrollment while reducing administrative burdens. By providing research sponsors, contract research organizations (CROs), and clinical research sites with real-time insights into recruitment and enrollment progress, OneStudyTeam allows users to concentrate on activities that significantly contribute to the success of clinical research. Founded in 2010 and based in Baltimore, Maryland, the company plays a crucial role in accelerating the development of new therapies, ultimately improving patient outcomes within the life sciences industry.
Unnatural Products Inc. is a biotechnology company based in Santa Cruz, California, specializing in drug discovery through the innovative use of macrocyclic peptides. Founded in 2016, the company employs artificial intelligence and computational biology techniques to engineer these peptides, allowing them to target previously undruggable protein interactions. By leveraging machine learning for parallel chemical synthesis, Unnatural Products aims to optimize macrocyclic compounds efficiently, thereby accelerating the drug discovery process. This technology addresses a significant gap in therapeutic strategies, offering potential treatments for a wide range of diseases linked to difficult-to-target drug candidates.
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.
UniKey Technologies, Inc. is a company that specializes in access control solutions, offering a platform that transforms smartphones into universal electronic keys. Founded in 2010 and based in Winter Park, Florida, the company provides a smart lock system that includes touch-to-open technology, allowing users to unlock doors without removing their smartphones from pockets or purses. UniKey's platform features advanced intelligence that determines whether an authorized user is present before granting access, enhancing security and preventing unauthorized entry. The company collaborates with lock manufacturers, including Kwikset and Weiser, to develop integrated smart lock solutions like Kevo. Additionally, UniKey offers a cloud-based lock management system tailored for multifamily properties and commercial businesses, which simplifies key management and access control across various applications, including residential, hospitality, and automotive sectors.
Welkin Health, Inc. is a San Francisco-based company that develops patient management software aimed at enhancing healthcare delivery. Founded in 2013, the platform is designed to guide healthcare teams through patient care by automating workflows and ensuring timely interventions for patients. It enables health workers to focus on individuals who require immediate attention, fostering stronger patient-provider relationships. The software also facilitates connections between health plans, providers, and patients through various communication channels, including phone, text, video, and email. Additionally, Welkin Health's platform is customizable and scalable, supporting a wide range of care areas such as mental health, chronic disease management, and women's health, thereby promoting increased patient engagement and outcome-based care.
Mightier is a gaming platform designed to assist children in regulating their emotions through scientifically-backed methods. Founded in 2016 and based in Boston, Massachusetts, the platform features bioresponsive video games developed in collaboration with Boston Children's Hospital and Harvard Medical School. The games utilize a biofeedback heart rate monitor that adjusts the difficulty level based on the player's emotional state, helping children learn to manage their feelings in real-time. By engaging with these interactive experiences, children with behavioral and emotional challenges can discover their emotional strengths and develop skills to harness their emotions in everyday situations.
Signal Vine, Inc. is a company that develops an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. The platform features targeted messaging, an intuitive interface, case management, hybrid messaging, and comprehensive reporting and analytics. By leveraging Blended Messaging and incorporating artificial intelligence, Signal Vine enables organizations to send personalized messages to students, alumni, and staff, thereby improving engagement and supporting timely actions. The platform is utilized by K-12 schools, higher education institutions, nonprofit organizations, and government programs to enhance student outcomes, streamline communication, and foster enrollment and persistence. Founded in 2013, the company is headquartered in Alexandria, Virginia.
Carta Healthcare, Inc. is a technology company that has developed a software-as-a-service platform to enhance the patient journey within hospitals by utilizing data from existing IT systems. Founded in 2016 and headquartered in San Mateo, California, Carta's platform aims to personalize care by identifying past patients with similar profiles and analyzing their experiences. By employing machine learning, the platform predicts potential bottlenecks, alerts facilities about recovery bed shortages, and forecasts the needs and expectations of current patients. Additionally, Carta combines artificial intelligence with skilled human expertise to improve the efficiency and quality of healthcare data management, ultimately enabling health systems to achieve more effective data abstraction.
InCarda Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops transformative therapies for cardiovascular diseases that enable patients to use in the first moments of acute cardiovascular symptoms. The company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics, Inc. was formerly known as Pleiades Cardio-Therapeutics, Inc. and changed its name to InCarda Therapeutics, Inc. in May 2011. The company was founded in 2009 and is based in Newark, California.
Properly, Inc. is a technology company that offers a platform and mobile application designed to streamline vacation rental property management, focusing on housekeeping and maintenance operations. Founded in 2014 and based in San Francisco, Properly serves property owners, managers, and service providers by providing a visual checklist tool that facilitates clear communication of turnover instructions. The company's mission is to ensure consistent and efficient cleaning processes for hosts and property managers, while enabling professional cleaners to meet client expectations and receive recognition for their work. Properly's services allow property managers to uphold brand standards, manage their teams effectively, and access real-time data, contributing to cost-effective property maintenance.
3T Biosciences, Inc. is an immunotherapy company established in 2017 and based in Menlo Park, California. The company focuses on developing innovative treatments for cancer and other T-cell-mediated diseases by utilizing synthetic biology and machine learning technologies. Its approach involves discovering novel targets for drug development, which aims to enhance the effectiveness of cancer therapies. Through its research and development efforts, 3T Biosciences is committed to providing healthcare professionals with advanced treatment options for patients facing cancer-related illnesses.
Huiseoul is an e-commerce company based in Seoul, South Korea, specializing in the online retail of Korean beauty products. It offers personalized skincare counseling alongside a range of cosmetic products, primarily targeting the Chinese market. In addition to its retail operations, Huiseoul develops various technological solutions, including front-end and back-end systems, APIs, chat servers, and a mobile application, to enhance its conversational e-commerce services.
Huiseoul is an e-commerce company based in Seoul, South Korea, specializing in the online retail of Korean beauty products. It offers personalized skincare counseling alongside a range of cosmetic products, primarily targeting the Chinese market. In addition to its retail operations, Huiseoul develops various technological solutions, including front-end and back-end systems, APIs, chat servers, and a mobile application, to enhance its conversational e-commerce services.
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.
Signal Vine, Inc. is a company that develops an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. The platform features targeted messaging, an intuitive interface, case management, hybrid messaging, and comprehensive reporting and analytics. By leveraging Blended Messaging and incorporating artificial intelligence, Signal Vine enables organizations to send personalized messages to students, alumni, and staff, thereby improving engagement and supporting timely actions. The platform is utilized by K-12 schools, higher education institutions, nonprofit organizations, and government programs to enhance student outcomes, streamline communication, and foster enrollment and persistence. Founded in 2013, the company is headquartered in Alexandria, Virginia.
Indi Molecular, Inc. is a life sciences company based in Culver City, California, that specializes in developing a synthetic class of diagnostic and therapeutic agents known as protein-catalyzed capture (PCC) agents. Founded in 2013 as a spinout from Integrated Diagnostics, the company utilizes “click chemistry” to create PCCs, which possess antibody-like properties with advantages such as improved selectivity, superior binding affinity, and significantly lower molecular weight compared to traditional monoclonal antibodies. These agents serve a dual purpose, functioning as precision-targeted therapeutics and in vivo imaging agents, enhancing the identification of biomarkers in diagnostics and therapeutic applications. The development of PCCs was a collaborative effort with the California Institute of Technology, reflecting the company's commitment to innovation in the life sciences sector.
UniKey Technologies, Inc. is a company that specializes in access control solutions, offering a platform that transforms smartphones into universal electronic keys. Founded in 2010 and based in Winter Park, Florida, the company provides a smart lock system that includes touch-to-open technology, allowing users to unlock doors without removing their smartphones from pockets or purses. UniKey's platform features advanced intelligence that determines whether an authorized user is present before granting access, enhancing security and preventing unauthorized entry. The company collaborates with lock manufacturers, including Kwikset and Weiser, to develop integrated smart lock solutions like Kevo. Additionally, UniKey offers a cloud-based lock management system tailored for multifamily properties and commercial businesses, which simplifies key management and access control across various applications, including residential, hospitality, and automotive sectors.
Amygdala Neurosciences, Inc. discovers, develops, and commercializes pharmacotherapies to treat and prevent addiction. The company offers ANS-6637, a chemical entity selective and reversible aldehyde dehydrogenase 2 (ALDH2) inhibitor that prevents pathophysiologic dopamine surge without changes to basal dopamine. Its chemical entity prevents drug seeking behavior, craving, and relapse. The company was incorporated in 2015 and is based in Palo Alto, California.
Thunder Creative Management Platform removes creative friction to allow advertisers to build more ads, faster. By doing so, Thunder scales ad creatives across devices, formats, and volume. Thunder's ad platform powers display, social, and mobile advertising for over 100 brands, media companies, and agencies. Notable customers include InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst.
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company’s DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreement with ImmunoPrecise Antibodies Ltd. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.
3T Biosciences, Inc. is an immunotherapy company established in 2017 and based in Menlo Park, California. The company focuses on developing innovative treatments for cancer and other T-cell-mediated diseases by utilizing synthetic biology and machine learning technologies. Its approach involves discovering novel targets for drug development, which aims to enhance the effectiveness of cancer therapies. Through its research and development efforts, 3T Biosciences is committed to providing healthcare professionals with advanced treatment options for patients facing cancer-related illnesses.
Welkin Health, Inc. is a San Francisco-based company that develops patient management software aimed at enhancing healthcare delivery. Founded in 2013, the platform is designed to guide healthcare teams through patient care by automating workflows and ensuring timely interventions for patients. It enables health workers to focus on individuals who require immediate attention, fostering stronger patient-provider relationships. The software also facilitates connections between health plans, providers, and patients through various communication channels, including phone, text, video, and email. Additionally, Welkin Health's platform is customizable and scalable, supporting a wide range of care areas such as mental health, chronic disease management, and women's health, thereby promoting increased patient engagement and outcome-based care.
Womply, founded in 2011, is a technology company focused on helping local businesses succeed in the digital landscape. It provides a local commerce platform that includes a range of applications, APIs, and financial tools tailored for over 500,000 American businesses. Womply's offerings are underpinned by the Womply Commerce Graph, a proprietary data asset that delivers comprehensive insights into local commerce dynamics. The platform features tools for online presence management, reputation management, and customer and revenue analytics, enabling local businesses to effectively manage their operations, marketing efforts, and growth strategies.
Non Equity Assistance in 2016
Mozio, Inc. operates an online airport transportation search and booking engine, enabling travelers to find and reserve various ground transportation options, including shared ride shuttles, private vans, taxis, limousines, and SUVs from airports across the globe. The platform aggregates local transportation services in regions such as the United States, Canada, Latin America, Europe, and Asia, simplifying the process of navigating from the airport to the final destination. Founded in 2012 and based in San Francisco, Mozio also offers API and affiliate programs, allowing travel websites and agents to sell transportation services. The company's mission is to enhance the travel experience by providing users with comprehensive information and the best deals for their ground transportation needs.
InCarda Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops transformative therapies for cardiovascular diseases that enable patients to use in the first moments of acute cardiovascular symptoms. The company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics, Inc. was formerly known as Pleiades Cardio-Therapeutics, Inc. and changed its name to InCarda Therapeutics, Inc. in May 2011. The company was founded in 2009 and is based in Newark, California.
Evidation Health develops a health data analytics platform that collects and analyzes continuous behavior data alongside healthcare information to enhance health outcomes. Founded in 2012 and headquartered in San Mateo, California, the company utilizes raw, high-frequency data from various sources such as sensors, devices, and video to generate insights into health and disease. Its products include a Data Platform, which transforms everyday behavior data into actionable health measures, and Studies, a service for conducting real-world research that incorporates behavioral data to support clinical and commercial teams. Evidation Health connects digital health companies with healthcare providers and payers, facilitating a better understanding of how everyday behaviors influence health. The company's offerings also encompass health outcomes research, technology assessment, and predictive analytics services.
ViewPoint Therapeutics, a biotechnology company founded in 2014 and based in San Francisco, focuses on developing treatments for diseases caused by protein misfolding, particularly cataracts. The company is advancing its research on crystallin stabilizers, which are small molecules designed to prevent and treat age-related cataracts and presbyopia. These stabilizers have shown promise in preclinical models through a systematic screening and optimization process. By targeting protein misfolding, ViewPoint Therapeutics aims to provide effective therapies for common age-related disorders, including cataracts and neurodegenerative diseases, ultimately enhancing treatment options for physicians and their patients.
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company’s DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreement with ImmunoPrecise Antibodies Ltd. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.
RallyPoint Networks, Inc. operates an online network designed for current and former U.S. military members, facilitating connections among service members, veterans, and their civilian supporters, such as family and recruiters. Founded in 2012 and based in Watertown, Massachusetts, RallyPoint serves approximately 1.7 million users, offering tools to help members succeed in their military careers and transition to civilian life. The platform allows users to build professional networks, connect safely with peers, and explore career opportunities both within the military and in the private sector. Additionally, RallyPoint assists in translating military experiences for civilian employers, enhancing job prospects for veterans. The company is a subsidiary of Student Veterans Of America, with Bob McDonald, a former CEO of Procter & Gamble and the 8th Secretary of Veterans Affairs, serving as chairman of its board.
WellDoc, Inc. is a digital health company focused on chronic disease management, particularly diabetes care. Founded in 2005 and headquartered in Baltimore, Maryland, WellDoc offers innovative solutions such as the DiabetesManager platform and BlueStar mobile prescription therapy. The DiabetesManager platform facilitates patient-provider coordination through features like personalized coaching, medication reminders, and real-time alerts, while BlueStar offers patients immediate guidance to enhance self-management of diabetes. WellDoc’s services also include clinical decision support for healthcare professionals and a comprehensive suite of technical services, such as software development and regulatory management. The company aims to improve health outcomes and reduce healthcare costs by integrating behavioral and motivational applications with everyday technology. WellDoc serves a diverse range of clients, including payors, employers, pharmaceutical and medical device companies, and healthcare providers.
Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the development of tissue-integrated sensors and biosensors aimed at enhancing diabetes management and chronic disease care. Founded in 2009, Profusa focuses on creating biointegrated sensors that allow individuals to monitor their unique body chemistry in real time, thereby transforming personal health management. The company's technology is designed to be user-friendly and cost-effective, providing actionable, clinical-grade data to improve health outcomes. Profusa also develops software that offers biofeedback for chronic disease management and promotes healthy living. Its flagship product, Lumee Oxygen, represents a significant advancement in continuous health monitoring within the European market.
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.
Thunder Creative Management Platform removes creative friction to allow advertisers to build more ads, faster. By doing so, Thunder scales ad creatives across devices, formats, and volume. Thunder's ad platform powers display, social, and mobile advertising for over 100 brands, media companies, and agencies. Notable customers include InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst.
Welkin Health, Inc. is a San Francisco-based company that develops patient management software aimed at enhancing healthcare delivery. Founded in 2013, the platform is designed to guide healthcare teams through patient care by automating workflows and ensuring timely interventions for patients. It enables health workers to focus on individuals who require immediate attention, fostering stronger patient-provider relationships. The software also facilitates connections between health plans, providers, and patients through various communication channels, including phone, text, video, and email. Additionally, Welkin Health's platform is customizable and scalable, supporting a wide range of care areas such as mental health, chronic disease management, and women's health, thereby promoting increased patient engagement and outcome-based care.
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company’s DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreement with ImmunoPrecise Antibodies Ltd. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.
Thunder Creative Management Platform removes creative friction to allow advertisers to build more ads, faster. By doing so, Thunder scales ad creatives across devices, formats, and volume. Thunder's ad platform powers display, social, and mobile advertising for over 100 brands, media companies, and agencies. Notable customers include InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst.
Amygdala Neurosciences, Inc. discovers, develops, and commercializes pharmacotherapies to treat and prevent addiction. The company offers ANS-6637, a chemical entity selective and reversible aldehyde dehydrogenase 2 (ALDH2) inhibitor that prevents pathophysiologic dopamine surge without changes to basal dopamine. Its chemical entity prevents drug seeking behavior, craving, and relapse. The company was incorporated in 2015 and is based in Palo Alto, California.
Evidation Health develops a health data analytics platform that collects and analyzes continuous behavior data alongside healthcare information to enhance health outcomes. Founded in 2012 and headquartered in San Mateo, California, the company utilizes raw, high-frequency data from various sources such as sensors, devices, and video to generate insights into health and disease. Its products include a Data Platform, which transforms everyday behavior data into actionable health measures, and Studies, a service for conducting real-world research that incorporates behavioral data to support clinical and commercial teams. Evidation Health connects digital health companies with healthcare providers and payers, facilitating a better understanding of how everyday behaviors influence health. The company's offerings also encompass health outcomes research, technology assessment, and predictive analytics services.
CardioGen Sciences
Seed Round in 2014
CardioGen Sciences is a biotechnology company that develops and offers gene therapy solutions for orphan-inherited arrhythmogenic diseases. It was founded in 2014 and is based in Palo Alto, California.
Womply, founded in 2011, is a technology company focused on helping local businesses succeed in the digital landscape. It provides a local commerce platform that includes a range of applications, APIs, and financial tools tailored for over 500,000 American businesses. Womply's offerings are underpinned by the Womply Commerce Graph, a proprietary data asset that delivers comprehensive insights into local commerce dynamics. The platform features tools for online presence management, reputation management, and customer and revenue analytics, enabling local businesses to effectively manage their operations, marketing efforts, and growth strategies.
LiquidM Technology GmbH, founded in 2013 and based in Berlin, Germany, offers a comprehensive advertising and campaign management platform designed for mobile media buyers, ad networks, and mobile operators. As a subsidiary of Smart AdServer SAS, LiquidM provides a white-labeled, cloud-based solution that allows users to set up and manage advertisements with customizable settings, targets, and supply partners. The platform supports integration with third-party solutions, including data management and attribution tools, facilitating efficient campaign execution. With a focus on modular design, LiquidM empowers agencies and advertisers to optimize their ad tech infrastructure, enhancing control and delivering deeper insights into media planning and purchasing. The company's technology combines media, data, and strategy to drive better results in the mobile display media marketplace, supporting real-time bidding and audience targeting based on various criteria.
Private Equity Round in 2014
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. The company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. Its flagship product, the Corus CAD test, is a blood-based gene expression test designed to help healthcare providers evaluate whether chest discomfort in non-diabetic patients is due to obstructive CAD. The company's innovations aim to improve treatment decisions, enhance patient outcomes, and reduce healthcare costs by providing actionable genomic information to clinicians. Established in 2003, CardioDx primarily serves customers across the United States.
Signal Vine, Inc. is a company that develops an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. The platform features targeted messaging, an intuitive interface, case management, hybrid messaging, and comprehensive reporting and analytics. By leveraging Blended Messaging and incorporating artificial intelligence, Signal Vine enables organizations to send personalized messages to students, alumni, and staff, thereby improving engagement and supporting timely actions. The platform is utilized by K-12 schools, higher education institutions, nonprofit organizations, and government programs to enhance student outcomes, streamline communication, and foster enrollment and persistence. Founded in 2013, the company is headquartered in Alexandria, Virginia.
Biomimedica is a medical device company that is pioneering new approaches to joint repair through its proprietary, synthetic cartilage technology. It was founded in 2007 and is based in South San Francisco, California, United States.
Benefitter helps employers confidently navigate Health Care Reform, save money, and improve their employees’ well-being.
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company’s DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreement with ImmunoPrecise Antibodies Ltd. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.
OneStudyTeam, a subsidiary of Reify Health, offers a cloud-based software platform designed to enhance the efficiency of clinical trial processes. The platform aims to simplify workflows for clinical trial teams, enabling faster and more predictable patient enrollment while reducing administrative burdens. By providing research sponsors, contract research organizations (CROs), and clinical research sites with real-time insights into recruitment and enrollment progress, OneStudyTeam allows users to concentrate on activities that significantly contribute to the success of clinical research. Founded in 2010 and based in Baltimore, Maryland, the company plays a crucial role in accelerating the development of new therapies, ultimately improving patient outcomes within the life sciences industry.
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company’s DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreement with ImmunoPrecise Antibodies Ltd. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.
Maverix Biomics brings together decades of experience and expertise in biologic research, bioinformatics, and enterprise application software development from many of today’s leading research institutions and technology companies. Their team combines leadership from successful Silicon Valley companies with world-class researchers from the University of California, Santa Cruz, to focus on one simple mission: to provide research scientists with an open, cloud-based platform integrating best-in-class open-source software that anticipates user needs, enables communities of discovery, and integrates data in context with the latest biomic information for viral, bacterial, vertebrate, and plant genomes.
Womply, founded in 2011, is a technology company focused on helping local businesses succeed in the digital landscape. It provides a local commerce platform that includes a range of applications, APIs, and financial tools tailored for over 500,000 American businesses. Womply's offerings are underpinned by the Womply Commerce Graph, a proprietary data asset that delivers comprehensive insights into local commerce dynamics. The platform features tools for online presence management, reputation management, and customer and revenue analytics, enabling local businesses to effectively manage their operations, marketing efforts, and growth strategies.
Indi Molecular, Inc. is a life sciences company based in Culver City, California, that specializes in developing a synthetic class of diagnostic and therapeutic agents known as protein-catalyzed capture (PCC) agents. Founded in 2013 as a spinout from Integrated Diagnostics, the company utilizes “click chemistry” to create PCCs, which possess antibody-like properties with advantages such as improved selectivity, superior binding affinity, and significantly lower molecular weight compared to traditional monoclonal antibodies. These agents serve a dual purpose, functioning as precision-targeted therapeutics and in vivo imaging agents, enhancing the identification of biomarkers in diagnostics and therapeutic applications. The development of PCCs was a collaborative effort with the California Institute of Technology, reflecting the company's commitment to innovation in the life sciences sector.
RallyPoint Networks, Inc. operates an online network designed for current and former U.S. military members, facilitating connections among service members, veterans, and their civilian supporters, such as family and recruiters. Founded in 2012 and based in Watertown, Massachusetts, RallyPoint serves approximately 1.7 million users, offering tools to help members succeed in their military careers and transition to civilian life. The platform allows users to build professional networks, connect safely with peers, and explore career opportunities both within the military and in the private sector. Additionally, RallyPoint assists in translating military experiences for civilian employers, enhancing job prospects for veterans. The company is a subsidiary of Student Veterans Of America, with Bob McDonald, a former CEO of Procter & Gamble and the 8th Secretary of Veterans Affairs, serving as chairman of its board.
LiquidM Technology GmbH, founded in 2013 and based in Berlin, Germany, offers a comprehensive advertising and campaign management platform designed for mobile media buyers, ad networks, and mobile operators. As a subsidiary of Smart AdServer SAS, LiquidM provides a white-labeled, cloud-based solution that allows users to set up and manage advertisements with customizable settings, targets, and supply partners. The platform supports integration with third-party solutions, including data management and attribution tools, facilitating efficient campaign execution. With a focus on modular design, LiquidM empowers agencies and advertisers to optimize their ad tech infrastructure, enhancing control and delivering deeper insights into media planning and purchasing. The company's technology combines media, data, and strategy to drive better results in the mobile display media marketplace, supporting real-time bidding and audience targeting based on various criteria.
Lark Technologies, Inc. is a developer of a chronic disease prevention and management platform headquartered in Mountain View, California. Founded in 2010, the company provides the Lark application, which utilizes artificial intelligence alongside human coaching to deliver personalized, real-time support for individuals managing chronic conditions such as diabetes, prediabetes, and hypertension. The platform also integrates data on user activity, sleep, and nutrition to enhance health outcomes. Lark's programs, including its CDC-recognized Diabetes Prevention Program and Hypertension Program, have garnered around 1.5 million users and are backed by clinical evidence published in peer-reviewed journals. The company serves employers and health plans, aiming to deliver compassionate care at scale.
Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the development of tissue-integrated sensors and biosensors aimed at enhancing diabetes management and chronic disease care. Founded in 2009, Profusa focuses on creating biointegrated sensors that allow individuals to monitor their unique body chemistry in real time, thereby transforming personal health management. The company's technology is designed to be user-friendly and cost-effective, providing actionable, clinical-grade data to improve health outcomes. Profusa also develops software that offers biofeedback for chronic disease management and promotes healthy living. Its flagship product, Lumee Oxygen, represents a significant advancement in continuous health monitoring within the European market.
Keepsafe Software Inc. is a company that specializes in digital privacy solutions, providing applications designed to protect personal content on mobile devices. Founded in 2012 and based in San Francisco, California, Keepsafe offers a suite of apps, including Keepsafe Photos, Keepsafe Documents, and AppLock, which allow users to secure and manage their private photos, videos, and documents. The software is available for both iOS and Android platforms and is designed to prevent unauthorized access to sensitive data, enabling users to maintain ownership over their digital privacy while providing options for safe sharing. Keepsafe aims to simplify the management of personal information in the digital realm, making privacy as straightforward as it is in the physical world.
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.
Evidation Health develops a health data analytics platform that collects and analyzes continuous behavior data alongside healthcare information to enhance health outcomes. Founded in 2012 and headquartered in San Mateo, California, the company utilizes raw, high-frequency data from various sources such as sensors, devices, and video to generate insights into health and disease. Its products include a Data Platform, which transforms everyday behavior data into actionable health measures, and Studies, a service for conducting real-world research that incorporates behavioral data to support clinical and commercial teams. Evidation Health connects digital health companies with healthcare providers and payers, facilitating a better understanding of how everyday behaviors influence health. The company's offerings also encompass health outcomes research, technology assessment, and predictive analytics services.
HealthTap is a virtual primary care platform focused on providing accessible and affordable healthcare. The company connects users with a network of U.S. doctors through various services, including text messaging, video appointments, and urgent care options. With more than 100,000 doctors and hundreds of millions of users across 170 countries, HealthTap enables patients to receive immediate assistance and guidance for their health concerns. Its augmented intelligence system helps users navigate their healthcare needs effectively, while also allowing them to choose and maintain a long-term relationship with their primary care physician. By collaborating with employers, insurance companies, and health systems, HealthTap aims to enhance the healthcare experience for both patients and providers, ultimately reducing costs and saving time in the process.
Synecor LLC is a medical device manufacturer based in Durham, North Carolina, with additional locations in California and North Carolina's Research Triangle Park. Founded in 2000 by Dr. Richard Stack, the company emerged from strategic collaborations with leading cardiologists, clinician-inventors, and scientists. Synecor specializes in developing innovative medical device technologies, focusing on minimally invasive treatments for obesity, bioerodible vascular stent platforms for coronary artery disease, and technologies for managing arrhythmias. The company also explores solutions for gastrointestinal interventions through natural orifices. By leveraging partnerships with prominent venture capital firms and major life sciences corporations, Synecor aims to address unmet medical needs across various specialties, including spine therapeutics and age-related conditions, facilitating quicker and more effective patient treatment.
Proteus Digital Health® is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicines includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making and data analytics to serve the needs of doctors and health systems. The goal of Digital Medicines is to empower patients and their families, enable physicians and health systems to more effectively manage risk and ensure that outcomes are reliably achieved.
Esperion Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing oral therapies for patients with elevated low-density lipoprotein cholesterol (LDL-C). Founded in 2008 and headquartered in Ann Arbor, Michigan, the company specializes in non-statin medications aimed at treating conditions such as atherosclerotic cardiovascular disease and heterozygous familial hypercholesterolemia. Its primary product candidates include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe), which are designed to improve cholesterol management. Esperion also explores novel treatment approaches, including HDL Therapy, based on its understanding of high-density lipoprotein function. The company collaborates with Daiichi Sankyo Europe GmbH to enhance its research and development efforts.
OneStudyTeam, a subsidiary of Reify Health, offers a cloud-based software platform designed to enhance the efficiency of clinical trial processes. The platform aims to simplify workflows for clinical trial teams, enabling faster and more predictable patient enrollment while reducing administrative burdens. By providing research sponsors, contract research organizations (CROs), and clinical research sites with real-time insights into recruitment and enrollment progress, OneStudyTeam allows users to concentrate on activities that significantly contribute to the success of clinical research. Founded in 2010 and based in Baltimore, Maryland, the company plays a crucial role in accelerating the development of new therapies, ultimately improving patient outcomes within the life sciences industry.
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.
Private Equity Round in 2012
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. The company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. Its flagship product, the Corus CAD test, is a blood-based gene expression test designed to help healthcare providers evaluate whether chest discomfort in non-diabetic patients is due to obstructive CAD. The company's innovations aim to improve treatment decisions, enhance patient outcomes, and reduce healthcare costs by providing actionable genomic information to clinicians. Established in 2003, CardioDx primarily serves customers across the United States.
Biomimedica is a medical device company that is pioneering new approaches to joint repair through its proprietary, synthetic cartilage technology. It was founded in 2007 and is based in South San Francisco, California, United States.
OneStudyTeam, a subsidiary of Reify Health, offers a cloud-based software platform designed to enhance the efficiency of clinical trial processes. The platform aims to simplify workflows for clinical trial teams, enabling faster and more predictable patient enrollment while reducing administrative burdens. By providing research sponsors, contract research organizations (CROs), and clinical research sites with real-time insights into recruitment and enrollment progress, OneStudyTeam allows users to concentrate on activities that significantly contribute to the success of clinical research. Founded in 2010 and based in Baltimore, Maryland, the company plays a crucial role in accelerating the development of new therapies, ultimately improving patient outcomes within the life sciences industry.
Terra Bella is a private company that provides commercial, high-resolution satellite imagery and high-definition video and analytics services. It analyzes the movement of goods and people; and provides visual data about supply chains, shipping, industrial plant activity, and humanitarian relief efforts. Terra Bella (originally Skybox Imaging) was co-founded by Dan Berkenstock, Julian Mann, John Fenwick, and Ching-Yu Hu in 2009 and is based in Mountain View, California, United States.
Keepsafe Software Inc. is a company that specializes in digital privacy solutions, providing applications designed to protect personal content on mobile devices. Founded in 2012 and based in San Francisco, California, Keepsafe offers a suite of apps, including Keepsafe Photos, Keepsafe Documents, and AppLock, which allow users to secure and manage their private photos, videos, and documents. The software is available for both iOS and Android platforms and is designed to prevent unauthorized access to sensitive data, enabling users to maintain ownership over their digital privacy while providing options for safe sharing. Keepsafe aims to simplify the management of personal information in the digital realm, making privacy as straightforward as it is in the physical world.
The Activity Exchange (AchieveMint) is a patient engagement platform focused on demonstrating health outcomes with digital health solutions and new approaches to predictive analytics. It provides incentives to patients who take healthy actions across a variety of mobile applications and to app developers who encourage those healthy actions. The Activity Exchange (AchieveMint) began as a collaboration between GE Ventures and Stanford Health Care to create a digital health enabled future. It was launched in 2012 by [Mikki Nasch](https://www.crunchbase.com/person/mikki-nasch), [Luca Foschini](https://www.crunchbase.com/person/luca-foschini#/entity), [Christine Lemke](https://www.crunchbase.com/person/christine-lemke#/entity), and [Alessio Signorini](https://www.crunchbase.com/person/alessio-signorini#/entity). It is based in San Francisco, C.A.
HealthTap is a virtual primary care platform focused on providing accessible and affordable healthcare. The company connects users with a network of U.S. doctors through various services, including text messaging, video appointments, and urgent care options. With more than 100,000 doctors and hundreds of millions of users across 170 countries, HealthTap enables patients to receive immediate assistance and guidance for their health concerns. Its augmented intelligence system helps users navigate their healthcare needs effectively, while also allowing them to choose and maintain a long-term relationship with their primary care physician. By collaborating with employers, insurance companies, and health systems, HealthTap aims to enhance the healthcare experience for both patients and providers, ultimately reducing costs and saving time in the process.
Tradeo Limited operates a social trading platform that caters to various participants in financial markets. Established in 2012 and headquartered in Douglas, Isle of Man, the company provides a comprehensive range of services, including market feeds, advanced charting, and trading in forex and contracts for difference (CFDs). The platform facilitates collaboration among users, enabling them to share market insights and strategies. Additionally, Tradeo offers access to the widely-used MetaTrader 4 (MT4) platform, which includes advanced technical analysis tools and automated trading systems. The company's partnership with FXGlobe enhances its service offerings, positioning Tradeo as an accessible and effective solution for both novice and experienced traders.
ICON Aircraft, Inc. designs, develops, manufactures, and markets light consumer sport aircraft. The company also operates an online store that sells aircraft gear, such as men’s apparel, women’s apparel, kids’ wear, hats, radio control games, and accessories. It markets its aircraft in the United States and internationally. ICON Aircraft, Inc. was founded in 2004 and is headquartered in Vacaville, California.
HealthTap is a virtual primary care platform focused on providing accessible and affordable healthcare. The company connects users with a network of U.S. doctors through various services, including text messaging, video appointments, and urgent care options. With more than 100,000 doctors and hundreds of millions of users across 170 countries, HealthTap enables patients to receive immediate assistance and guidance for their health concerns. Its augmented intelligence system helps users navigate their healthcare needs effectively, while also allowing them to choose and maintain a long-term relationship with their primary care physician. By collaborating with employers, insurance companies, and health systems, HealthTap aims to enhance the healthcare experience for both patients and providers, ultimately reducing costs and saving time in the process.
ImmunoCellular Therapeuti is a clinical-stage biotechnology company. It is engaged in developing immune-based therapies for the treatment of cancers which can elicit an immune response against several antigens. The company has developed ICT-107, which is a dendritic cell (DC) immunotherapy for the treatment of newly diagnosed glioblastoma multiforme (GBM), which is a lethal type of brain cancer. It develops Immunotherapies for treating cancer in which a patient's own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, dedicated to developing innovative antiviral therapeutics for patients with serious diseases, including cancer and those undergoing transplant procedures. The company’s lead candidate, CMX001, targets life-threatening double-stranded DNA viral infections and has demonstrated antiviral activity in clinical studies involving immunocompromised patients. Ongoing research includes a Phase 2 study for preventing cytomegalovirus in stem cell transplant recipients and other studies addressing adenovirus and various herpes viruses. Chimerix is also developing CMX157, a nucleoside analogue aimed at treating HIV and hepatitis B, which has shown promising results in early trials. Additionally, the company is working on dociparstat sodium, a compound intended to inhibit key proteins linked to acute myeloid leukemia, and brincidofovir, an antiviral candidate for smallpox. Chimerix holds various licensing agreements to advance its research and has received substantial federal funding to support its initiatives in public health and medical countermeasures.
Ooma, Inc. is a communications services company that specializes in cloud-based software and unified communications solutions for both businesses and consumers. Founded in 2003 and headquartered in Sunnyvale, California, Ooma offers a range of services designed to enhance communication and security. For businesses, the company provides Ooma Office, a multi-user communications system tailored for small and medium-sized enterprises, along with features like call recording and enhanced call blocking. For consumers, Ooma delivers high-definition voice quality through products such as Ooma Telo, which serves as a primary home phone line, and offers smart security solutions that include wireless sensors and a smart video camera. Ooma's services are available through direct sales, distributors, retailers, and online platforms. The company focuses on creating connected experiences that improve productivity and security in both workplace and home environments.
Rapidscan Pharma Solutions, Inc. is a pharmaceutical company focused on the development, manufacturing, and sale of Regadenoson, a pharmacological stress agent used for diagnosing and assessing cardiovascular disease. Founded in 2010, the company has secured licensing rights to market Regadenoson in various regions, including Europe, Latin America, Japan, Australia, New Zealand, and Israel. The agent plays a crucial role in myocardial perfusion imaging procedures, which are essential for diagnosing coronary artery disease, affecting millions of individuals in Europe alone. In 2017, Rapidscan Pharma Solutions became a subsidiary of GE Healthcare, further enhancing its operational capabilities in the healthcare sector.
Provade, Inc. specializes in providing an enterprise vendor management system focused on workforce management and procurement. Founded in 2004 and headquartered in Milwaukee, Wisconsin, with additional offices in Pleasanton, California; Highworth, United Kingdom; and Sydney, Australia, the company offers a range of services including identity management, implementation, training, support, and managed services. Its solutions empower users to analyze, manage, and control expenditures related to contingent workforce and statements of work. Provade also provides mobile applications for iPhone and Android, enabling workers in contingent labor programs to submit timesheets and expenses for approval. The company primarily serves enterprise technology firms, financial institutions, and manufacturing businesses on a global scale. As of February 2018, Provade operates as a subsidiary of Smart ERP Solutions Inc.
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. The company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. Its flagship product, the Corus CAD test, is a blood-based gene expression test designed to help healthcare providers evaluate whether chest discomfort in non-diabetic patients is due to obstructive CAD. The company's innovations aim to improve treatment decisions, enhance patient outcomes, and reduce healthcare costs by providing actionable genomic information to clinicians. Established in 2003, CardioDx primarily serves customers across the United States.
OfferIQ
Venture Round in 2010
OfferIQ bridges the gap between mobile coupon delivery and redemption in the physical shopping world.
HighTower is a advisor-owned financial services company. HighTower Advisors are free of those conflicts typically found in traditional brokerage firms. They are totally independent, yet fully supported in both viewing the financial lives of our clients more completely and working with them more effectively.
Kii Corporation, established in July 2010 through the merger of Servo Software and Synclore Corporation, specializes in providing Internet of Things (IoT) platforms and solutions for various sectors, including Smart Cities, Smart Buildings, Smart Logistics, and healthcare. The company offers a mobile backend-as-a-service platform that simplifies the development of IoT and mobile applications by managing multiple vendors and providing essential backend functionalities, such as user management and push notifications. This approach allows businesses to reduce both development and operational costs by eliminating the need to manage or operate servers, thereby streamlining the application development process.